Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Imitrex Prescribers (US)

Articles with lock require a subscription to GLG News | Request a free trial
April 4, 2007
Cymbalta: Propelling Eli Lilly to Higher Grounds
Analysis of: FDA Approves Duloxetine for Anxiety | journals.elsevierhealth.com
Author: GLG Expert Contributor
Anxiety disorders are among the most common neuropsychiatric disorders.  Pharmacological treatments are limited and typically associated with adverse side effects and potential drug dependence. There is a great need to develop novel pharmacological agents for improved treatment of these disorders....
April 3, 2007
Lamotrigine superior for partial epilepsy?
Analysis of: Research Finds Newer Drug for Partial Epilepsy Is Superior But Old Tops New For Generalised Seizures | www.medicalnewstoday.com
Author: GLG Expert Contributor
  The article reports on a British study suggesting that lamotrigine and valproic acid are respectively the best first line drugs for partial and generalized onset epilepsy.
April 3, 2007
Avicena begins NIH funded phase III trial of PD-02
Analysis of: Avicena Announces Patient Enrollment in National Institutes Of Health (NIH) Phase III Parkinson's Disease Trial | www.medicalnewstoday.com
Author: GLG Expert Contributor
  PD-02 is an ultra-pure form of creatine which may slow the progress of Parkinson’s Disease. A federal government sponsored phase III clinical trial has just begun to evaluate its efficacy.
April 3, 2007
Cox-2 inhibitor comeback?
Analysis of: Suffering boomers want to fill Vioxx void | www.contracostatimes.com
Author: GLG Expert Contributor
  The article states that Cox-2 inhibitors may be making a comeback to treat arthritis pain
April 3, 2007
Duloxetine (Cymbalta) gets new FDA approval
Analysis of: FDA Approves Duloxetine for Anxiety | journals.elsevierhealth.com
Author: GLG Expert Contributor
  Duloxetine has received FDA approval for the treatment of generalized anxiety disorder, based on the results of three studies of more than 800 subjects.
April 3, 2007
Anterior plating has higher fusion rate for single-disc-level procedures
Analysis of: Study Compares Benefits Of Surgical Treatments For Degenerative Spinal Disease - Higher Success Rates Shown In Procedures Using Plate System | www.medicalnewstoday.com
Author: GLG Expert Contributor
 This article reports on a meta-analysis comparing different surgical procedures for cervical fusion. Approaches with anterior plating provided the highest rates of fusion.
April 3, 2007
New device looks promising for improving motor function after stroke
Analysis of: MIT Brace Aids Stroke Recovery - Worn On The Arm, NeuroRobotic Device Is Lightweight, Portable | www.medicalnewstoday.com
Author: GLG Expert Contributor
  A new robotic brace developed by MIT researchers allows patients to have improved limb use by facilitating joint movement.
April 2, 2007
Triple Reuptake Inhibitors: “Mini” Antidepressants
Analysis of: Triple Reuptake Inhibitors: What to Expect from “Mega-Andipressants” | www.currentpsychiatry.com
Author: GLG Expert Contributor
There is a great need to develop new antidepressants with superior efficacy, better tolerability and faster onset of action since considerable adverse events including a higher risk of suicidal behavior occur in the first 6-9 days after initiation of antidepressant treatment.  Compounds that block...
April 2, 2007
Vaccines
Analysis of: Vaccines: What Does Cervical Cancer Have To Do With Chickenpox? | blogs.wsj.com
Author: GLG Expert Contributor
The article discusses current problems with the apparent short life of the chicken pox vaccine and mandatory vaccinations.
April 2, 2007
Walmart investing in new healthcare IT center
Analysis of: Wal-Mart And Partners Create Health-IT Research Center | informationweek.com
Author: GLG Expert Contributor
Wal-Mart has teamed with the University of Arkansas and Blue Cross Blue Shield to create a new health IT research center Its goals are to reduce medical errors and increase the efficiency of health care supply.

Previous Page : 1 2 3 4 5 6 7 Next41 to 50 of 67

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T13:45:22.747